Nicole (Nicki) Perry-Hauser is now available What a fun chat! 📹Would you like to see the video?

Stuart Maudsley, Nicole Perry-Hauser, Lauren Slosky, Cesare Orlandi, and Simone Prömel. Terry Kenakin's "Applying Pharmacology to Drug Discovery" course at Dr.

Nicole Perry-Hauser, on her selection as a 2024 Discovery Science Emerging Scholar at Vanderbilt University Terry Kenakin. The course covers basic pharmacology in four weekly segments.

Terry Kenakin.

Terry Kenakin, Dr. Oliver Hartley, Dr. Pierre Eftekhari, Dr. Lauren Slosky, Dr. Christel Menet, Dr.

Terry Kenakin's "Applying Pharmacology to Drug Discovery" course at Dr.

Terry Kenakin, was a resounding success; we have a waitlist for those eager to attend this course, which

Terry Kenakin.

Terry Kenakin. The course covers basic pharmacology in four weekly segments.

Terry Kenakin. The course covers basic pharmacology in four weekly segments. Only ten spots remain.

Terry Kenakin, have been amazing.

Terry Kenakin, starts February 8th, 2024. Due to popular demand, we have opened additional spots.

Terry Kenakin. The course covers basic pharmacology in four weekly segments.

Terry Kenakin. We would like to extend our heartfelt thanks to Dr.

Terry Kenakin.

Terry Kenakin’s Applying Pharmacology to Drug Discovery course.

Hébert and their colleagues research on 'G Protein-Biased Agonists for Intracellular Angiotensin Receptors

Terence Hébert’s work on Comparative study on human iPSC-derived vs. rat neonatal cardiomyocytes.

kinases, emphasizing their role as hubs for increasing local effector concentrations near active GPCRs (Perry-Hauser

Ferry, G. Paul Greengard (1925–2019).